title: Complete remission in acute myeloid leukaemia after treatment with recombinant human granulocyte colony-stimulating factor and high dose intravenous methylprednisolone.
authors.affiliation: Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sugawara
authors.forename: A
authors.initials: A
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Shishido
authors.forename: M
authors.initials: M
authors.lastname: Okuda
authors.forename: J
authors.initials: J
authors.lastname: Kameoka
authors.forename: K
authors.initials: K
authors.lastname: Meguro
authors.forename: K
authors.initials: K
authors.lastname: Endo
authors.forename: K
authors.initials: K
authors.lastname: Yoshinaga
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D004334:Drug Administration Schedule; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008775:Methylprednisolone